Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 278-282

  Ephros, Moshe ^a   Bitnun, Ari ^a   Shaked, Pninit ^a   Waldman, Ella ^a   Zilberstein, Dan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; MEGLUMINE ANTIMONATE;

AMASTIGOTE; ARTICLE; CROSS RESISTANCE; DRUG EFFECT; LEISHMANIA DONOVANI; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; VISCERAL LEISHMANIASIS;

EID: 0032990769     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.278     Document Type: Article

References (33)

1. Bates, P. A. 1994. Complete developmental cycle of Leishmania mexicana in axenic culture. Parasitology 108:1-9.
2. Bates, P. A., C. D. Robertson, L. Tetley, and G. H. Coombs. 1992. Axenic cultivation and characterization of Leishmania mexicana amastigote-like forms. Parasitology 105:193-202.
3. Berman, J. D., J. D. Chulay, L. D. Hendricks, and C. N. Oster. 1982. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. Am. J. Trop. Med. Hyg. 31:459-465.
4. Berman, J. D., D. Waddell, and B. D. Hanson. 1985. Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate. Antimicrob. Agents Chemother. 27:916-920.
5. Borst, P., and M. Ouellette. 1995. New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49:427-460.
6. Callahan, H. L., A. C. Portal, R. Devereaux, and M. Grogl. 1997. An axenic amastigote system for drug screening. Antimicrob. Agents Chemother. 41: 818-822.
7. Chang, K. P., and D. M. Dwyer. 1976. Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vivo. Science 193:678-680.
8. Chang, K. P., D. Fong, and R. S. Bray. 1985. Biology of Leishmania and leishmaniasis, p. 1-30. In K. P. Chang and D. Bray (ed.), Leishmaniasis. Elsevier, Amsterdam, The Netherlands.
9. Detke, S., K. Katakura, and K. P. Chang. 1989. DNA amplification in arsenite-resistant Leishmania. Exp. Cell Res. 180:161-170.
10. Dey, S., M. Ouellette, J. Lightbody, B. Papadopoulou, and B. P. Rosen. 1996. An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc. Natl. Acad. Sci. USA 93:2192-2197.
11. Dey, S., B. Papadopoulou, G. Roy, K. Grondin, D. Dou, B. P. Rosen, M. Ouellelte, and A. Haimeur. 1994. High level arsenite resistance in Leishmania tarentolae is mediated by active extrusion system. Mol. Biochem. Parasitol 67:49-57.
12. Doyle, P. S., J. C. Engel, P. F. Pimenta, P. P. Da Silva, and D. M. Dwyer. 1991. Leishmania donovani: long-term culture of axenic amastigotes at 37°C. Exp. Parasitol 73:326-334.
13. Dwyer, D. M. 1977. Leishmania donovani: surface membrane carbohydrate of promastigotes. Exp. Parasitol. 41:341-358.
14. Ephros, M., E. Waldman, and D. Zilberstein. 1997. Pentostam induces resistance to antimony and preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Antimicrob. Agents Chemother. 41:1064-1068.
15. Faraut-Gambarelli, F., R. Piarroux, M. Deniau, B. Giusiano, P. Marty, G. Michel, B. Faugere, and H. Dumon. 1997. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agents Chemother. 41:827-830.
16. Grogl, M., T. N. Thomason, and E. D. Franke. 1992. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47:117-126.
17. Grondin, K., A. Haimeur, R. Mukhopadhyay, B. P. Rosen, and M. Ouellette. 1997. Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J. 16:3057-3065.
18. Haimeur, A., and M. Ouellette. 1998. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate. Antimicrob. Agents Chemother. 42:1689-1694.
19. Hodgkinson, V. H., L. Soong, S. M. Duboise, and D. McMahon-Pratt. 1996. Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms. Exp. Parasitol. 83:94-105.
20. Hubel, A., S. Brandau, A. Dresel, and J. Clos. 1995. A member of the ClpB family of stress proteins is expressed during heat shock in Leishmania spp. Mol. Biochem. Parasitol 70:107-118.
21. Ibrahim, M. E., M. Hag-Ali, A. M. El-Hassan, I. G. Theander, and A. Kharazmi. 1994. Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing. Parasitol. Res. 80:569-574.
22. Jaffe, C. L., and N. Rachamim. 1989. Amastigote stage-specific monoclonal antibodies against Leishmania major. Infect. Immun. 57:3770-3777.
23. Joshi, M., D. M. Dwyer, and H. L. Nakhasi. 1993. Cloning and characterization of expressed genes from in vitro-grown 'amastigotes' of Leishmania donovani. Mol. Biochem. Parasitol 58:345-354.
24. Legare, D., B. Papadopoulou, G. Roy, R. Mukhopadhyay, A. Haimeur, S. Dey, K. Grondin, C. Brochu, B. P. Rosen, and M. Ouellette. 1997. Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Exp. Parasitol. 87:275-282.
25. Mebrahtu, Y., P. Lawyer, J. Githure, J. B. Were, R. Muigai, L. Hendricks, J. Leeuwenburg, D. Koech, and C. Roberts. 1989. Visceral leishmaniasis unresponsive to Pentostam caused by Leishmania tropica in Kenya. Am. J. Trop. Med. Hyg. 41:289-294.
26. Mukhopadhyay, R., S. Dey, N. Xu, D. Gage, J. Lightbody, M. Ouellette, and B. P. Rosen. 1996. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc. Natl. Acad. Sci. USA 93:10383-10387.
27. Olliaro, P. L., and A. D. M. Bryceson. 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol. Today 9:323-328.
28. Roberts, W. L., J. D. Berman, and P. M. Rainey. 1995. In vitro antileishmanial properties of tri- and pentavalent antimonial preparations. Antimicrob. Agents Chemother. 39:1234-1239.
29. Roberts, W. L., and P. M. Rainey. 1993. Antileishmanial activity of sodium stibogluconate fractions. Antimicrob. Agents Chemother. 37:1842-1846.
30. Saar, Y., R. Asamoa, E. Waldman, S. Mazareb, S. Amin-Spector, J. Plumblee, S. J. Turco, and D. Zilberstein. 1998. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani. Mol. Biochem. Parasitol 95:9-20.
31. Shapira, M., G. McEwen, and C. L. Jaffe. 1988. Temperature effect in molecular processes which lead to stage differentiation in Leishmania. EMBO J. 7:2895-2901.
32. Zilberstein, D., and A. Gepstein. 1993. Regulation of L-proline transport in Leishmania donovani by extracellular pH. Mol. Biochem. Parasitol 61:197-206.
33. Zilberstein, D., and M. Shapira. 1994. The role of pH and temperature in the development of Leishmania parasites. Annu. Rev. Microbiol. 48:449-470.